Literature DB >> 28006694

Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs.

Laurien M Buffart1, Joeri Kalter2, Maike G Sweegers3, Kerry S Courneya4, Robert U Newton5, Neil K Aaronson6, Paul B Jacobsen7, Anne M May8, Daniel A Galvão9, Mai J Chinapaw10, Karen Steindorf11, Melinda L Irwin12, Martijn M Stuiver13, Sandi Hayes14, Kathleen A Griffith15, Alejandro Lucia16, Ilse Mesters17, Ellen van Weert18, Hans Knoop19, Martine M Goedendorp20, Nanette Mutrie21, Amanda J Daley22, Alex McConnachie23, Martin Bohus24, Lene Thorsen25, Karl-Heinz Schulz26, Camille E Short27, Erica L James28, Ron C Plotnikoff29, Gill Arbane30, Martina E Schmidt31, Karin Potthoff32, Marc van Beurden33, Hester S Oldenburg34, Gabe S Sonke35, Wim H van Harten36, Rachel Garrod37, Kathryn H Schmitz38, Kerri M Winters-Stone39, Miranda J Velthuis40, Dennis R Taaffe41, Willem van Mechelen42, Marie-José Kersten43, Frans Nollet44, Jennifer Wenzel45, Joachim Wiskemann46, Irma M Verdonck-de Leeuw47, Johannes Brug48.   

Abstract

This individual patient data meta-analysis aimed to evaluate the effects of exercise on quality of life (QoL) and physical function (PF) in patients with cancer, and to identify moderator effects of demographic (age, sex, marital status, education), clinical (body mass index, cancer type, presence of metastasis), intervention-related (intervention timing, delivery mode and duration, and type of control group), and exercise-related (exercise frequency, intensity, type, time) characteristics. Relevant published and unpublished studies were identified in September 2012 via PubMed, EMBASE, PsycINFO, and CINAHL, reference checking and personal communications. Principle investigators of all 69 eligible trials were requested to share IPD from their study. IPD from 34 randomised controlled trials (n=4519 patients) that evaluated the effects of exercise compared to a usual care, wait-list or attention control group on QoL and PF in adult patients with cancer were retrieved and pooled. Linear mixed-effect models were used to evaluate the effects of the exercise on post-intervention outcome values (z-score) adjusting for baseline values. Moderator effects were studies by testing interactions. Exercise significantly improved QoL (β=0.15, 95%CI=0.10;0.20) and PF (β=0.18, 95%CI=0.13;0.23). The effects were not moderated by demographic, clinical or exercise characteristics. Effects on QoL (βdifference_in_effect=0.13, 95%CI=0.03;0.22) and PF (βdifference_in_effect=0.10, 95%CI=0.01;0.20) were significantly larger for supervised than unsupervised interventions. In conclusion, exercise, and particularly supervised exercise, effectively improves QoL and PF in patients with cancer with different demographic and clinical characteristics during and following treatment. Although effect sizes are small, there is consistent empirical evidence to support implementation of exercise as part of cancer care.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Exercise; Individual patient data meta-analysis; Neoplasm; Physical function; Quality of life

Mesh:

Year:  2016        PMID: 28006694     DOI: 10.1016/j.ctrv.2016.11.010

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  140 in total

1.  Total energy expenditure in patients with colorectal cancer: associations with body composition, physical activity, and energy recommendations.

Authors:  Sarah A Purcell; Sarah A Elliott; Peter J Walter; Tom Preston; Hongyi Cai; Richard J E Skipworth; Michael B Sawyer; Carla M Prado
Journal:  Am J Clin Nutr       Date:  2019-08-01       Impact factor: 7.045

Review 2.  Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the Microbiome.

Authors:  Allison Betof Warner; Jennifer L McQuade
Journal:  Curr Oncol Rep       Date:  2019-07-01       Impact factor: 5.075

3.  Cancer survivors' experiences of a community-based cancer-specific exercise programme: results of an exploratory survey.

Authors:  Susan Catt; J Sheward; E Sheward; H Harder
Journal:  Support Care Cancer       Date:  2018-04-05       Impact factor: 3.603

4.  Predictors of attendance to an oncologist-referred exercise program for women with breast cancer.

Authors:  Kelcey A Bland; Sarah E Neil-Sztramko; Amy A Kirkham; Alis Bonsignore; Cheri L Van Patten; Donald C McKenzie; Karen A Gelmon; Kristin L Campbell
Journal:  Support Care Cancer       Date:  2018-04-13       Impact factor: 3.603

Review 5.  The Importance of Body Composition in Explaining the Overweight Paradox in Cancer-Counterpoint.

Authors:  Bette J Caan; Elizabeth M Cespedes Feliciano; Candyce H Kroenke
Journal:  Cancer Res       Date:  2018-04-15       Impact factor: 12.701

Review 6.  Impediments to clinical application of exercise interventions in the treatment of cardiometabolic disease.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2019-03       Impact factor: 3.275

7. 

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2019-03       Impact factor: 3.275

8.  Heart rate variability and heart rate recovery in lung cancer survivors eligible for long-term cure.

Authors:  Duc Ha; Atul Malhotra; Andrew L Ries; Wesley T O'Neal; Mark M Fuster
Journal:  Respir Physiol Neurobiol       Date:  2019-07-31       Impact factor: 1.931

9.  Municipality-based pragmatic rehabilitation stratified in accordance with individual needs-results from a longitudinal survey study.

Authors:  Sine Rossen; Karen Trier; Berit Christensen; Martina A Eriksen; Ann-Dorthe Zwisler; Jette Vibe-Petersen
Journal:  Support Care Cancer       Date:  2019-08-02       Impact factor: 3.603

10.  Physical activity and quality of life in African American cancer survivors: The Detroit Research on Cancer Survivors study.

Authors:  Jennifer L Beebe-Dimmer; Julie J Ruterbusch; Felicity W K Harper; Tara M Baird; David G Finlay; Andrew G Rundle; Stephanie S Pandolfi; Theresa A Hastert; Kendra L Schwartz; Gerold Bepler; Michael S Simon; Julia Mantey; Judy Abrams; Teri L Albrecht; Ann G Schwartz
Journal:  Cancer       Date:  2020-02-24       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.